Legal & General Group Plc - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 84 filers reported holding MERSANA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$67,517
-71.8%
53,162
-27.0%
0.00%
Q2 2023$239,633
+60.0%
72,837
+99.8%
0.00%
Q1 2023$149,810
-27.4%
36,450
+3.6%
0.00%
Q4 2022$206,208
-10.0%
35,189
+3.8%
0.00%
Q3 2022$229,000
+57.9%
33,887
+7.4%
0.00%
Q2 2022$145,000
+43.6%
31,546
+24.7%
0.00%
Q1 2022$101,000
-35.3%
25,295
+0.7%
0.00%
Q4 2021$156,000
-33.9%
25,1140.0%0.00%
Q3 2021$236,000
+24.2%
25,114
+79.3%
0.00%
Q2 2021$190,000
-10.4%
14,006
+6.9%
0.00%
Q1 2021$212,000
-41.4%
13,097
-3.7%
0.00%
Q4 2020$362,000
+42.0%
13,605
-0.7%
0.00%
Q3 2020$255,000
-26.5%
13,702
-7.5%
0.00%
Q2 2020$347,000
+1185.2%
14,818
+213.6%
0.00%
Q1 2020$27,000
-20.6%
4,725
-21.2%
0.00%
Q4 2019$34,000
+277.8%
5,9950.0%0.00%
Q3 2019$9,000
-62.5%
5,9950.0%0.00%
Q2 2019$24,000
+140.0%
5,995
+210.1%
0.00%
Q1 2019$10,000
+25.0%
1,9330.0%0.00%
Q4 2018$8,000
-57.9%
1,9330.0%0.00%
Q3 2018$19,000
-45.7%
1,9330.0%0.00%
Q2 2018$35,000
+12.9%
1,933
-1.1%
0.00%
Q1 2018$31,000
+158.3%
1,955
+178.1%
0.00%
Q4 2017$12,0000.0%7030.0%0.00%
Q3 2017$12,0007030.00%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Sarissa Capital Management LP 4,005,600$64,810,0006.21%
Bain Capital Life Sciences Investors, LLC 3,695,667$59,796,0003.39%
COMMODORE CAPITAL LP 429,228$6,945,0002.77%
ACUTA CAPITAL PARTNERS, LLC 357,689$5,787,0002.09%
Avoro Capital Advisors LLC 6,800,000$110,024,0001.90%
Ghost Tree Capital, LLC 450,000$7,281,0001.71%
RHO CAPITAL PARTNERS INC 796,458$12,887,0001.24%
Rock Springs Capital Management LP 2,775,127$44,902,0000.98%
Sio Capital Management, LLC 157,259$2,544,0000.52%
Bellevue Group AG 2,850,010$46,113,0000.49%
View complete list of MERSANA THERAPEUTICS INC shareholders